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We know that cytochrome P450 plays a role in the toxification and/or
detoxification of many xenobiotics. We also know that P450 is found in many
organisms including bacteria and man. So when man is exposed to a certain
xenobiotic (e.g. food dye), bacteria in the intestine are also exposed to the
xenobiotic. The purpose of this study was to determine the role of intestinal
bacteria in the detoxification of xenobiotics in the intestine. Major strains of
intestinal bacteria were screened for the presence of cytochrome P450, which is
not known to exist currently in intestinal bacteria. The results of this study will
contribute towards our understanding of how intestinal bacteria respond to
xenobiotics, and to determine the role intestinal bacteria play in xenobiotic
metabolism as it relates to cancer and bioremediation research.
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Chapter I
Introduction and Literature Review
History of Cytochrome P450
For many years a war has been raging between plants and animals.
When animals first began crawling out of the ocean in search of new food
sources, they encountered land plants. Initially, land plants were not affected,
but, as time passed, these animals began to ingest plants. As a defense
mechanism, plants produced stress metabolites called phytoalexins, which made
plants less palatablie and/or digestible. In turn, animals responded with the
production of an enzyme system called cytochrome P450, which detoxified these
phytoaexins «1]).
Cytochrome P450 may have evolved from bacteria millions of years ago.
Bacterial evolution pre-dates drugs, animal-plant warfare, and the combustion of
organic matter. Therefore, it is possible that P450 may have played a role in the
oxidation of the atmosphere (Le. the reduction of Nitrogen). Cytochrome P450
may also have played a role in oxygen-detoxification during the chemical
evolution period, as P450 may have been involved in converting H202 to H20
([2], [3], and [4n.
In the early 1950's, a new type of cytochrome found in rat liver
microsomes was observed ([5]). A broad absorption band with a maximum
absorption at 450 nm detected after treating the sample with a reducing agent
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and carbon monoxide (CO). This absorption band was later called the CO
difference absorption spectrum.
Later, other investigators confirmed the presence of the absorbance
spectrum using microsomes isolated from pig liver ([6]). In addition, these
studies determined that the reducing agent dithionite had a similar redox
potential as cysteine, thereby, suggesting that the protein(s) in piQi liver
microsomes oontained a metal ion ([6]).
I,n the early 1960's, the term PA50 was coined ([7). DurinQi this time
investigators determined that cytochrome P450 was not related to other known
cytochromes such as cytochrome bs. In addition, investigators determined that
the PA50 protein was a hemoprotein. Further characterization of cytochrome
P450 revealed the denatured form of the protein produced an unusual
characteristic absorption peak at 420 nm ([7]). In addition, it was determined that
cytochrome P450 had characteristics of a b-type cytochrome ([8)).
In 1968, the first bacterial P450 from Pseudomonas putida (P450CAM)
was isolated ([9]). The P450CAM was confirmed as a b-type cytochrome with an
iron protoporphyrin IX-containing protein. In 19'85, P450CAM was the first three-
dimensional crystal structure of cytochrome P450 to be determined ([10)). The
crystall structure was later used as a model to provide information on the
structure and function of bacterial and mammalian P450s.
2
Characteristics of Cytochrome P450
The unique spectral, property of all cytochrome P450s is the production of
the 450 nm spectral peak. The 450 nm peak is due in part to the heme-iron
binding to the sulfur atom on the amino acid cysteine. Specifically, the fifth ligand
of the heme binds to cysteine, while CO binds at the sixth ligand on the opposite
side of the heme ([11]). The cysteine residue is near several highly conserved
proteins, thereby, making up the largest conserved region of the protein. In
addition, other minor conserved regions exist.
Most all known bacterial cytochrome P450s consist of a two-protein
system, except for Bacillus megaterium. B. megaterium has three distinct P450
systems. One of the three P450 proteins in B. megaterium called BM-3 has a
one-protein system, in which the FAD, FMN, and a P450 heme moiety make-up
the large 119 kDa protein. The protein is self-suffICient as the protein combines
both the el,ectron transport functions and substrate oxygenation function in one
large molecule. BM-3 was first detected as a fatty acid hydroxylase in cell-free
preparations and later lidentified as a P450 ([12]). BM-3 is inducible by
phenobarbital, and is one of only two bacterial P450 systems (the other being
from Str:eptomyces griseo/us ([13]) that are inducible by phenobarbital (a
xenobiotic which is a man-made or foreign compound). The other two P450
proteins., BM-1 and BM-2, have a two-protein system. BM-1 has a molecular
weight near 47kDa and resembles P450CAM from P. putida ([12]). BM-2 has a
molecular weight of 48 kDa and is poorly characterized, as the protein has not
been cloned intact.
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Cytochrome P450s are G1assifiHd as a super-family of heme proteins.
P450s are divided into families and sub-famili.es based on amino acid sequence
identity. If the amino acid sequence is >40% identical to an existing famUy, then
that P450 sequence lies within the same family. If a P450 protein sequence from
one gene family is ~ 40% identical to an existing family, it will be placed in a
separate family ([14]). A sub-family is a branch of a family in which more than
one P450 enzyme exists. A cytochrome P450 gene is designated as CYP (from
gytochrome P450). Different cytochrome P450s are distinguished by Arabic
number and letter designations. For example, CYP3A4, the Arabic number
denotes the family, the letter designates the subfamily, and second Arabic
number represents the individual gene within the subfamily.
An interesting aspect of the cytochrome P450 protein includes a signature
amino acid sequence FxxGxxxCxG, where the cysteine of the CxG refers to the
enzyme active-cysteine ([14]). There are no prokaryotic sequences that deviate
from the original signature sequence, however a few eukaryotic sequences have
slight deviations. Currently, there are 74 gene families and within that number,
only 14 families (which include 26 sub-families) are mammalian associated ([14]).
There are three general types of compounds that are known to induce the
different cytochrome P450 systems: 1) drugs, 2) toxic or carcinogenic
compounds and 3) steroids. Most cytochrome P450 systems are inducible, but
the mechanism of the induction is not well understood. What is known is that the
induction of P450 into bacterial systems can be classified into three categories:
1) substrate induction and substrate analogs, 2) non-substrate induction by
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exogenous or endogenous substances and, 3} induction hy environmental
factors ([12]). In addition, P450 induction hy phenobarbitall is said to be a
regulated process in mammals, avian species, and in bacteria ([15]). In
mammals, induction with phenobarbital causes a 50- to 1DO-fold increase in the
P450 protein, mRNA, and transcription initiation. In bacteria, the activation of
transcription for P450BM-3 is under positive control (presence of inducer), as a
transacting factor protein interacts with the 5'-flanking region of the BM-3 gene.
Based on similar sequence identity at the 5'-flanking region for both mammals
and bacteria, the regulatory mechanisms associated with phenobarbital induction
may be similar for both systems.
Figure 1 shows the three cytochrome P450 protein systems. The three
systems are based on the minimum number of protein components necessary to
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Fig. 1. Cytochrome P450 protein systems. Comparisons of mitochondrial,
microsomal, and bacterial P450 enzyme systems ([12]).
Recently, a fourth type of P450 was identified, P450nor. P450nor is
unique in that it receives its electrons directly from reduced pyridine nucleotides
without the intervention of an electron carrier (reductase or redoxin) ([16]).
Intestinal Microflora
Different specific intestinal bacterial (microflora) populations exist in
humans depending on diet, but, in general, the various kinds of bacterial species
present in the intestine are the same for all individuals. There have been more
than 400 bacterial species identified from feces, with anaerobic bacteria being
the predominant type of microorganism ([17], [18], [19], and [20]). The diversity
and abundance of bacteria in the gut are reflected in their collective metabolic
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activities, which are extensive and variled. They include hydrolysis, reduction,
and oxidation. Microflora interact with the host locally by intimate contact with
the intestinal mucosa. and systemically by influencing diverse ,respol1lses and
functions - immunological, physiological, anatomical, metabolic, nutritional. and
toxicologicall ([21]).
Intestinal flora possess phase I and II enzymes. which are involved in the
modification and elimination of detoxified and toxi.fied products from living
organisms. Phase I and phase II enzymes are also found in hepatic tissue,
where they play a similar role. One function of phase I and II enzymes is the
metabolism of drugs. Specifically. phase I enzymes introduce a functional group,
such as OH, into the substrate. Phase II enzymes use this functional group as a
"handle" for conjugation, ylieldin9 a hydrophilic product, thereby, promoting the
excretion of the generated product ([1], [22]).
The microflora and liver are believed to function together through a
process called hepatic recycling. The intake of some oral medications are
initially metabolized by microflora using phase I and II enzymes. Some of these
products may absorb into the intestine and make their way to the liver. The
phase I and II enzymes from the liver will further metabolize the compound. After
passage through the liver, the compounds that are less than 56 kDa are excreted
into the kidneys where they are eliminated as urine. Larger molecules re-enter
the intestine via the bile (hepatic cycling) and are eliminated via feces. In some
instances the compound or its metabolites may be re-absorbed and circulated
back to the liver ([22}).
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Since the liver and intestinal flora both possess phase I and tI enzyme
systems, certa1in enzyme reactions in the l!iver are similar to those in bacterial
flora. For example, azoreductase is a phase I enzyme, that is present in
mammals and bacteria.. Azoreductase reduce azo dyes to amines, which can be
mutagenic and carcinogenic. Specifically, the azoreductase in mammalian liver
has been identified as cytochrome P450. Unfortunately, the structure and
function of bacterial azo-reductase is not fully characterized ([23]). Therefore,
bacterial azo-reductase maybe a cytochrome P450 protein. In addition, there
has not been an extensive study to determine the presence of cytochrome P450
in intestinal microflora.
Due to the diverse metabolic capacity of intestinal microflora, and the lack
of information regarding the specific enzymes present in specific species of
bacteria, the proposed study seeks to use a number of molecular biology,
biochemistry and microbiology techniques to investigate the presence of
cytochrome P450 in intestinal microflora.
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CHAPTER II
peR ampUflcation to screen for P450
Introduction
Cytochrome P450 may have evoilved from bacteria millions of years ago.
Therefore, a number of conserved regions may exist between mammalian and
bacterial systems, as well as, among the many diverse species of bacteria.. This
study used a number of cytochrome P450 conserved regions in bacteria to
screen other species of bacteria for the presence of P450. Based on this
approach, several methodologies for the screening of various intestinal bacterja
(Table 1) were developed to screen for the presence of cytochrome P450. First,
specific primers were designed based on conserved amino acid regions in P450
from Pseudomonas putida (P450CAM) and Bacillus megaterium (P450BM-3).















Table 1: Bacterial species studied uSing PCR.
All strains were obtained from American Type Culture Collection (ATCC).
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Second, different DNA sample preparation methods were tested using the PCR
technique. They included: 1) whole cell, 2) chromosomal, and 3) cDNA
preparations. Third, two methods of PCR product analysis were tested. They
included 1) electro-elution and 2) the TA vector method. The efficiency and
accuracy of the methods was tested by DNA sequence determination.
The methods developed were su bsequently used through out the study to
screen intestinal flora for the presence of cytochrome P450.
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Methods and Matelrials
Whole cell PCR: lyophmzed whole ce!lls were used to PCR amplified
DNA. Twelve ATCC strains were tested (Table 1). The lyophilized cells were
first re-suspended in 1 ml ddH20. The PCR reaction mixture contained: 1iO ~d
amount af 10X PCR buffer-minus Mg2+(Promega, Madison, WI), 6 IJI 0.25 mM
MgCb, 2 III 10mM dNTPs, 1 ).lg of primer (Table 2), 1 ml TIE (10 mM Tris-CI, 1
mM IEDTA, pH 8.0), 5 III whole oell suspension, 0.51J.1 Taq polymerase (2.5 units)
and the volume was brought up to 100 III using ddH20. The mixture was
centrifuged briefly (5 seconds) and overlaid with 60 III mineral oil.
peR conditions: PCR amplification was performed in a Perkin Elmer
Cetus Thermo Cycler (Norwalk, CT). The following cycles were used: One cycle
at 94°C for five minutes, 55°C for five minutes, and 72°C for five minutes. Thes,e
were followed by 30 cycles using the same temperature, but the incubation times
were changed to one minute alii temperatures. An extension step was performed
at the end of the 30 cycles in which the sample was incubated at 72°C for five
minutes. The final step was a 4°C soak.
Large-scale preparation of bacterial genomic DNA: A 100 ml sample of
bacterial culture was grown overnight and. subsequently centrifuged in a Sorvall
centrifuge (GSA-13 rotor, Newtown, CT) for 10 minutes at 4000 rpm at 4°C. The
pellet was re-suspended in 9.5 ml TIE, 0.5 ml 10% SOS and 50 III of 20 mg/ml
proteinase K, vortexed, and incubated for one hour at 3rC. A 1.8 ml amount of
5M NaCI was added and vortexed. Then, a 1.5 ml CTAB/NaCI solution was
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added, vortexed again and incubated at 65°C for 20 minutes. An equal volume
of chloroform-isoamyl al:cohol (24:1) was added, vortexed and centrifuged for 10
minutes at 6000 rpm at room temperature. The top layer was transferred to a
fresh micro-centrifuge tube and an equal volume of phenol-chJoroform-isoamyl
alcohol (24:24:1) was added. The sample was i:nverted 5 times and centrifuged
(Eppendorf model 5415c) at 14,000 rpm for 10 minutes. The top layer was
transferred to a fresh micro-centrifuge tube. A 0.6 volume, of isopropanol was
added in order to precipitate the DNA. The sample was centrifuged for 10
minutes at 14,000 rpm, at room temperature. The supernatant was removed and
the precipitate was washed with 70% ethanol, (EtOH), air-dried and re-suspended
in a 100 ~I amount of TE buffer. Approximately, 2~g of chromosomal DNA was
used in the peR reactions.
mRNA isolation: The Micro-FastTrack Kit from Invitrogen (Carlsbad, CA)
was used to isolate mRNA. Briefly, the bacterial cells were washed and re-
suspended in a lysis buffer.. Cellulose was used to bind nucleic acid, allowing
mRNA to be isolated from the column. The mRNA was then washed from the
cellulose.
eDNA synthesis: The 3' RACE kit from Gibco BRL (Rockville, MD) was
used to synthesize the eDNA. The mRNA served as tile template for the AP
primer binding. Figure 2 demonstrates the procedure used to synthesize and
test the eDNA, using specific primers. Reverse transcriptase allowed the
synthesis of the eDNA from mRNA. The eDNA then served as the template for
the binding of specific primers (Table 2).
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PCRele.ctrophoresis: A 2%agarose gel (Sigma. St. Louis MO) in TAE
(O.04 M tris-acetate and f)JJ01 M EDTA) was used to analyze all peR products~
TA vector method: The TA cloning kit from Invitrogen (Cart-shad. CAl was




I I I J 1TTITI'JIIV.iI':'"]I'y-;;'··:jt'"]F··.-~--,1. 5'
AP
Extend by using Superscript It reverse
transcriptase
.2) 5' AMM MAn













Extend using Taq polymerase
--- "-....
3) 3' ......f---------------TTTTT....TITT,...".Il7""7}1.....· ----,15'
3667.....




Fig. 2: RT-PCR was performed on a mRNA strand of E. coli using the 3' RACE
kit from Gibco BRL. AP is an amplified primer that has oligo T and Mfu I, Spel,
Sal I sites and a half Not I site. 3667 is a specific primer from P. putida and
AUAP is the Abridged Universal amplification primer from the Gibeo BRL 3'
RACE kit.
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Electro-elution method:, The agarose gel containing the DNA band was
cut out and placed in dialysis tubing (12-14 kDa). Approximately 300 ~I TAE
buffer was added to the diallysis tubing. The dialysis tubing, which contained the
gel was sealed and placed in an electrophoresis unit. The unit was set for 30
minutes at 80 vollts. After the electrophoresis, a 10-second reverse pulse
(reverse positive and negative wires) was performed. The TAE/DNA mixture was
removed from the dialysis tubing and placed in a micro-centrifuge tube. One-half
the volume of 7.5M ammonium-aoetate was added with 2 times the volume of
95% EtOH. The tube was vortexed and placed on ice for 10 minutes. The
suspension was then centrifuged (Eppendorf model 5415c) at 14,000 rpm for 5
minutes at room temperature.. The supernatant was removed and the DNA-pellet
was rinsed with 80% EtOH and centrifuged again at 14,000 rpm for 2 minutes at
room temperature. The supernatant was removed and the pellet was air-dried.
The pellet was re-suspended in 75 III TE buffer.
Nucleotide sequencing: AU sequencing was performed at the
Recombinant DNA/Protein Resource Facility at Oklahoma State University
(OSU).
Plasmid extraction: The Qiagen Plasmid Midi kit (Valencia, CA) was used
for the extraction of TA plasmids.
Basic local Alignment Search Tool (BLAST) (f23]1 The BLAST program
was used to analyze the sequence information. BLASTP compared an amino
acid query sequence against a protein sequence database. BLASTN compared
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a nucleotide query sequence against a nucleotide sequence database. BLASTX
compared a nudeotide query sequence, transl,ated in all reading frames against
a protein sequence database. TBLASTN compared a protein query sequence
against a nucleotide sequence database, dynamically translated in aU reading
frames. The output from each BLAST search had two critical sets of data: 1) an
expected value (e-value), and 2) the score number. The e-value was a
parameter that described the number of random hits one could expect to see
when searching a database of a particular size. The e-value decreased
exponentially with the score number. The score number was assigned to a
match between two sequences.










Table 2. Nuclleotide sequence of PCR primers used. 2533, 2534, and 3576 were
specific primers for P. putida. 3667 was used for RT-peR and was specific for P.
putida P450cam. 2676 and 2677 were specific primers for BM-1. 2678, 2679,
and 2680 were specific primers for BM-3 ..
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Results
The approach used in the study was based on previous studies in which
the assumption was made that consensus P450 sequences (conserved regions)
from one or more species, representing one or more P450 subfamilies, would be
represented in the unknown P450 being targeted for cloning ([24]). To test for
existing P450 gene sequences in intestinal microflora, the two most extensively
studied bacterial P450 systems, P450CAM·and BM-3 and BM-1, were used to
synthesize several primers specific for the conserved regions. A reverse
nucleotide primer was designed based on the universally conserved amino acid
cysteine region (FxxGxxxCxG) from P. putida. Two forward nucleotide primers
were designed based on other minor conserved regions. In addition, two forward
and two reverse nucleotide primers were constructed, based on conserved and
overlapping amino acid regions from B. megaterium.
To determine the best method to use to screen bacteria for the presence
of cytochrome P450, several DNA and PCR preparation methods were tested.
Initial testing involved P. putida P450CAM (Fig. 3) and B. megaterium BM-1 and
BM-3 (Fig. 4 and 5), as they were used as positive controls. First, chromosomal
DNA from P. putida was used to test the primers 2534 and 2533. The results
produced a predicted size fragment of 200 bp (Table 3). The first method tested
for the isolation of PCR fragment and sequencing was the electro-elution
method. All PCR products were sequenced at the Recombinant DNA/Protein
Resource Facility at OSU. The peR-DNA sequence was compared to the
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nucleotide sequence for P450CAM using the DNASI:S program. The PGR-DNA
sequence matched 94% for the entire length of P. putida P450CAM. Mis-
matches were seen at the beginning and end of the sequence, which is typically
observed with this sequenc,jng approach.
Primer Pair Predicted size fragment Species
2533-2534 200 bp P. putida
2533-3576 350 bp P. putida
2676-2677 1000 bp B. meqaterium
2678-2679 800 bp B. meqaterium
2678-2680 1200 bp B. meqaterium











Fig. 3: Representation of the Pseudomonas putida CAM gene and its
corresponding primers.. Primers 3576 and 2534 are specific upstream (forward)
primers. Primer 2533 is a specific downstream (reverse) primer and represents
the conserved cysteine region. Primer 3667 is a specific primer used in the RT-
peR method (Shaded areas represent conserved regions).
The primers identified in Fig .. 4 and Fig. 5 were used to amplify P450 from
the control plasmid (pUC13 containing BM-3), a gift from Dr. Fulco (The
University of California-Los Angeles) and from B. megaterium chromosomal
DNA. The predicted size fragments for all primer combinations were generated.
They included a 900 bp (2678/2680 primer combination), 1.2 kbp (2678/2679






(Table 3). The sequence information was used to perform a BLASTN search.
The search revealed the peR-DNA sequence had a 95% homology to its







Fig. 4: Representation of the BM-1 gene from B. megaterium. 2678 is a specific
upstream primer. 2679 and 2680 are specific downstream primers.
To maximize the efficiency of testing twelve intestinal microbes, the whole
cell peR approach was used. Of the twelve bacterial strains tested (whole cell)
only E. coli produced a 250 bp fragment, which was near the predicted size
mgion of 200 bp. E. coli was further investigated as the chromosomal DNA was
obtained. Using primers 2533 and 3576, which produces a predicted size
fragment of 350 bp, the genomic DNA was PCR amplified. The genomic DNA
produced an 800 bp fragment, which was not the predicted size product. Due to
the intensity of the 800 bp fragment and the possibility of it containing a P450
sequence, the PCR fragment was isolated by electro-elution and sequenced at
the Recombinant DNA/Protein Resource Facility at OSU.
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The sequence was analyzed directly by BLASTN and BLASTX. The
BLASTN resulted in a score of 418 with 829 bits and an e-value of 0, which is
translated as a 94% homology to section 189 of 400 of the E. coli chromosome.
The BLASTX resulted in a score of 752 with 297 bits and an e-value of 6e-82.
The identity was 83% to the putative nucleoside permease protein, from E. coli.
To determine if section 189 was, in fact, the putative nucleoside permease
protein a TBLASTN was performed.. The TBLASTN of the putative nucleoside
permease protein resulted in a score of 913 with 360 bits and an e-value of e-






Fig. 5: Representation of the BM-3 gene from B. megaterium. 2676 is a specific
upstream primer and 2677 is a specific downstream primer.
Possibly, the predicted size fragment, using primers 2533 and 3576, for E.
coli was not generated due to competing nucleic material. Therefore,
optimization of the peR procedure was attempted by isolating only mRNA from
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the bacteria. The RT-PCR technique was used to isolate mRNA. The rationale
behind this approach is some bacterial species produce a poly A tai.l, including E.
coli. Therefore, it is possible to only collect mRNA containing a poly A tail. while
eliminating other nucleic acid material that may ·interfere in the PCR reaction.
The mRNA approach resulted in the formation of three bands, 200. 350, and 800
bp using the 3576 and 2533 primers. The peR sampile containing all three
bands were ligated into the TA cloning vector (Invitrogen). The plasmids were
then transformed into competent cells. Ten positive colonies were isolated. The
plasmid was extracted and cut with an EcoRI restriction enzyme, in order to
release the insert. Three samples oontained inserts and were 800 bp in length.
The TA vector containing the 800 bp fragment was purified and sequenced. A
BLASTN was executed and the sequence matched to the E. coli chromosome
with a score of 158 with 313 bits and an e-value of 2e-85, which is 99% identical
to section 31 of 400 from E. coli, Performing a BLASTX resulted in a score of
387 and 167 bits and an e-value of 1e-42, which is 98% identical to the beta-D-
galactosidase protern of E. coli. To determine if the protein beta-D-galactosidase
from E. coli matched section 31 of 400 on the E. coli chromosome, a partial
amino acid sequence from beta-D-galactosidase was compared, The TBLASTN
results were identical to section 31 of 400 for E. coli.
The 800 bp product information from genomic DNA and mRNA were
different.. The primer bound to different regions on the E. coli chromosomal DNA
and eDNA. It was concluded that the primers did not have a high homology to
the regions they bound, thereby, non-specific binding occurred. To determine if
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E. coli contained sequences similar to cytochrome P450, the P450GAM
sequence was compared to the E. coli chromosome database (recent sequence
of the entire genome). A BLASTN search did not result in any significant
homology between P450CAM and the E. coli chromosome. !In addition, the
BLASTX results did not result in any signi:ficant homology to E. coli proteins.
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Discussion t·
Different methods were successfully developed in order to screen
intestinal bacteria ·for the presenoe of cytochrome P450. These methods
involved designing specific conserved primers, and developing procedures for
the peR portion of the study. The initial investigation tested twelve different
ATCC intestinal bacterial strains. The ATCC strains were selected based on
their importance as major human intestinal flora ((25]). The results from the initial
investigation determined that E. coli was the only strain that produoed a predicted
size PCR product. Therefore, E. coli was used to develop and test the different
methods, as well as, determining whether the cytochrome P450 gene was indeed
present in the bacterium. The development of these methods included testing
whole cells, chromosomal, and cDNA amplification. In addition. different
methods of PCR product isolation and analysis were developed.
There were three methods tested that involved preparing DNA for 'the
peR reaction. All three methods were tested using the same PCR reaction
conditions. It was concluded that the whole cell PCR method did not yield a clear
PCR fragment Thus, sequence information could not be obtained. The
chromosomal extraction method resulted in an increase in PCR product
generation. In an attempt to improve the PCR reaction) a cleaner DNA
preparafion was attempted. Messenger RNA was initially isolated and cDNA was
synthesized ([26]). The eDNA then served as the template, thereby, eliminating
the presence of other l1ucleic acid material that would interfere with the peR
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reaction. The cDNA method did result in the amplification of unique DNA
amplified fragments that were not present in the chromosomall preparation.
Once the peR products were produced, two methods of PCR fragment
preparation for purpose of sequencing were tested. The evaluation criteria for
the two methods were based on the generation of clear sequence information.
The two methods tested were 1) the electro-elution method, and 2) the TA
cloning method. The electro-elution method was more accurate when a single
band was clearly isolated from other bands in a lane. In comparison, the TA
cloning kit produced a higher yield of PCR product, thereby, making it more
efficient for peR sequencing.
The primers used in the study were homologous to P450 conserved
regions. Unfortunately, the primers did not produce the predicted peR fragment
from the selected strain, nor did the PCR fragment contain sequences similar to
existing P450 families. Therefore, either no P450 was present in E. coli or a new
P450 family may be present.
A comparison of the entire P. putida P450CAM nucleotide sequence with
the entire E. coli genome revealed no significant homology between the two. A
comparison of the amino acid: sequence from P450CAM with E. coli proteins also
did not show any significant homolo9Y. The results support a review by Munro
([27]), which reported that E. coli appeared to be devoid of P450. However, an
E. coli electron-transfer system, capable of supporting the function of a
heterologously-expressed P450, does exist.
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Recent completion of the entire genome sequence for the E. coli K-12
strain revealed that no cytochrome P450 gene from an existing family was
present ([28]). It should be noted that the E. coli strain used in this study was
isolated from human intestinal feces ([25]) and is different from the E. coli K-12
strain. To determine if the intestinal strain used in this study contains a new




Phenobarbital Induction in Intestinal Microflora
Introduction
Cytochrome P450 is inducible by a number of different compounds (e.g.
xenobiotics, nitrates, and azo-dyes). The induction of cytochrome P450 in tum
can result in the metabolism of a number of different man-made or foreign
compounds called xenobiotics (drugs, dyes, pesticides, etc.). Therefore, one
method of identifying new cytochrome P450s is to induce the protein with existing
inducers such as phenobarbital. Since phenobarbital is a common inducer for
mammalian and bacterial systems, it was used in this study as an inducer to
screen a number of intestinal bacteria for the presence of cytochrome P450.
Since the enzyme systems in intestinal bacteria (over 400 species) have
not been fully characterized, it is possible that cytochrome P450 may exist in
intestinal bacteria. In addition, there has not been an extensive study to
determine the presence of cytochrome P450 in major intestinal strains such as
Bacteroides spp., Bifidobacterium spp., Fusobacterium spp. and Clostridium
spp..
To determine the presence of cytochrome P450 in major strains of
intestinal flora, eighteen bacterial strains were grown in the presence of
phenobarbitaL The strains were selected based on reports by Moore regarding





Preparation of anaerobic media: Two different types of media were used
1.) (Tryptone, Yeast Extract and Glucose (TYG) and 2.) Bli8in Heart Infusion
(BHI». TYG: For 500 ml of medium, the following were added- 5 9 of tryptone,
2.5 9 yeast extract, 425 ml dH20, 12.5 ml salt solution 1 (3 9 KzHP04 in 1 liter
water), 12.5 ml salt sol!ution 2 (3.54 g; KHzP04, 9 9 (NH4)2S04, 0.9 9 NaCI, 1.9 9
MgS04 in 500 ml water), 12.5 ml CaCb solution (0.6 9 CaCh in 1 liter water), 2.0
ml hemin (50 mg hemin, 1 ml 1N NaOH in 100 ml water), 1 ml Wolfe's mineral
solution(2X) (1.5 9 nitrilotriacetic acid, 3 9 MgS04-7H20, 0.5 9 MnS04.H20, 1 9
NaCl, 0.1 9 FeS04-7H20, 0.1 9 CoCI2-6HzO, 0.1 9 ZnS04-7HzO, 0.01 9
CuS04-5HzO, 0.01g AIK(S04)Z-12H20, 0.01 9 H3B03 , O.01g NazMo04-2HzO into
500 ml water) and 5.0 ml resazurin (0.25 9 resazurin in 500 ml water) were
added. The medium was then boiled using a microwave for 5 minutes and
degassed (bubbled) with N2 for 30 minutes. When the TYG was approximately
40°C, 5 ml vitamin K solution (50 mg menadione in 100 ml 95% EtOH) and 0.3 9
cysteine-HCI were added. The pH was adjusted to 7.0. The solution was then
bubbled for another 10 minutes. In a separate bottle, 10 ml H20, 10 ml volatile
fatty acids (42.5 ml acetic acid, 15.0 ml propionic acid, 10.0 ml butyric acid, 2.5
ml isobutyric acid, 2.5 ml valerie acid, 2.5 ml isovaleric acid and 2.5 ml
methylbutryic acid with the pH adjusted to 9.5 and the volume made up to 500 ml
with ddH20) and 0.2 9 sodium carbonate were added to a 100 ml bottle. The
bottle was sealed and autoclaved with the TYG solution.
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After autoclaving, N2 was bubbled into the TYG solution until the solution was
less than 50°C. Aseptically, 20 ml 20% anaerobic glucose, 20 ml volati;le fatty
acid, 10 ml reducing agent (110 ml distilled water microwaved tor two minutes,
gassed with N2 until room temperature, then 2.5 9 cysteine-Hel was added, the
pH adjusted to 9.0 using 5 N NaOH, and 2.5 9 Na2S.gH20 were added and
pl,aced in N2 equilibrated bottles, and autoclaved) and 1 ml 10X vitamins (5 mg
ribofl!avin, 100 '1!9 Vitamin B12, 5 mg pyridoxine(B6), 5 mg pyridoxal, 5 mg
pyridoxamine, 5 mg pantothenate-Ca, 3 mg nicotinic acid, 3 mg nicotinamide, 2
mg biotin, 2 mg folic acid, 5 mg thiiamine(B1), 5 mQi thioctic acid and 5 mg: p-
amino benzoic acid were added to 50 ml distilled water and filter sterilized
(O.2I!m) and placed into N2 equilibrated bottles and sealed) were added to the
solution, completing the TYG medium. The medium was placed in an anaerobic
chamber and incubated at 3JOC overnight to test for contamination.
BHI medium preparation was similar to TYG, except tryptone was
replaced with 18 g brain heart infusion and 12.5 g yeast extract was added
instead of 2.5g from the TYG recipe.
Inoculation of media: From an active sample of bacteria growing (24 -48
hrs) in Chopped Meat Carbohydrate (Anaerobe Systems Morgan Hill. CA), 100 /-ll
was transferred to 5 ml of BHI and incubated overnight at 37°C. Phenobarbital
(inducer) was filter sterilized (0.2I!m) and added for a final concentration of 5 mM
into one of two bottles of anaerobic media (according to Table 4). The overnight
culture was divided into two equal parts and inoculated into both bottles (with and
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without inducer). The sample was incubated for 24 to 48 hours at 37°C or untH
visually turbid.
Protein Extraction: The 5,00 ml culture of bacteria (induced or non-
induced) was separated into two equal parts in N2 equilibrated 250 ml Nalgene
anaerobic bottles, Using a Sorvall centrifuge (GSA-13 rotor, Newtown, GT), the
samples were centrifuged at 10,000 rpm for 15 minutes at 4°C. After
centrifugation, the bottles were placed baclk into the anaerobi.c chamber and the
supernatant removed. Each pellet was washed with 10 ml of anaerobic Mops
buffer (100 mM Mops (pH 7.3), 10% glycerol, 0.2 mM dithiothreitol, and 1mM
EDTA) and combined for a total of approximately 20 ml Mops buffer. The
suspension was then transferred to a N2-equilibrated 50 ml centrifuge tube and
sealed with an anaerobic cap. The suspension was again centrifuged at 10,000
rpm for 15 minutes at 4°G. In the anaerobic chamber, the supernatant was
removed and 10 ml of fresh Mops buffer was added and the pellet was re-
s~spended. For Gram-positive bacteria, 10J.l1 mutanolysin was added and the
sample incubated for two hours at 37°C. The suspension was placed on ice for 2
minutes. Once cooled, the sample (Gram-positive or Gram-negative) was
sonicated unde~. N2 gas. Using a flat tip sonicator probe (Branson Sonic Power
Co., Danburry, GT), the sample was pulsed for 2-seconds, 25 times. The sample
was placed on ice for 2 mil1utes and the above step was repeated twice. lin the
anaerobic chamber, the sample was transferred to an ultra-centrifuge tube that
was equilibrated with N2. The sample was centrifuged in the Ultra-centrifuge at
31. ,000 rpm for 35 minutes at 4°C in a Ti-70 rotor. In the anaerobic chamber, the
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supernatant was fractionated into 1.5 ml ar:laerobic tubes that were equilibrated
with Nz. The supernatants were labeled fraction 1 and stored at -80°C. A 10 ml
amount of Mops buffer containing CHAPS (final concentration of 0.5%) was
added to the pellet. The sample was capped and stirred overnight at 4°C with a
metal stir bar and magnetic stirrer. The ultra-centrifugation and fractionation
steps were repeated. The second fraction was labelied fraction 2 and also stored
at -80°C.
Protein determination: To determine the protein concentration, two protein
assays were used: 1) Bio-Rad DC (Detergent Compatible) (Bio-Rad, Hercules
CA) and 2) the Folin reaction. (Note: two different assays were used, due to
available chemicals). The Folin reaction was comprised of four reagents.
Reagent A (2 g of Na2C03 in 100 ml of 0.1 N NaOH) was added to reagent B
(0.05 g of CuS04.5 H20 in 10 ml of a 1% (w/v) solution of sodium tartrate) at a
50: 1 ratio to make reagent C. Reagent D was 1 N Falin-Phenol. At total of 100!-L1
of protein (fraction 1 and fraction 2) was added to 300111 of water. Then, 2 ml of
reagent C was added and vortexed. This mixture was incubated at room
temperature for 10 minutes. Then 200 III of reagent 0 was added, vortexed, and
incubated for 30 minutes. The absorbance was analyzed at 750 nm using a
Shimadzu spectrophotometer (Columbia, MD). The Bio-Rad DC assay followed
the manufactures protocol.
CO difference spectrum: The CO difference spectrum assay was used to
detect a 450nm peak from the protein fractions ([29]). To determine the CO
difference absorbance spectra, 1 ml of the protein fraction (1 and 2) were
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thawed. Sodium hydrosulfite (final concentration of 10 mM) was added to the
fraction. The fraction was inverted 5 times and the absorbance was scanned
from 400 to 600 nm in order to establish a base line. CO was then bubbled
through the sample for approximately 30 seconds. The absorbance of the
sample was then scanned again. The sample was rescanned 5 minutes later.
Protein prepar~tion for SDS-PAGE: Based on the protein determination
assay, four volumes (600 lll) methanol, 1 volume (150!lI) chloroform and 3
volumes (450 Ill) distilled water were added to 100119 of the protein sample. The
sample was vortexed for 30 seconds and centrifuged for 5 minutes at 14,000 rpm
(Eppendorf model 5415c). The upper layer was discarded, leaving the interface
and lower layer. To the interface and lower layer, 300 III methanol was added
and inverted 5 times. Again, the sample was centrifuged for 5 minutes at 14,000
rpm. The supernatant was removed and the subsequent pellet dried (Speed-
Vac) for 10 minutes to remove residual methanol. To the dry pellet, 20 III distilled
water and 5f.l1 4X tracking dye (3.8 ml distilled water, 1 ml 0.5 M tris-Hel at a pH
6.8,800 ttl glycerol, 1.6 ml 10% (w/v) 80S, 400 III p-mercaptoethanol and 0.05%
(w/v) bromophenol blue) wer,e added. The sample was boiled for 5 minutes,
vortexed, and then centrifuged for 2 minutes at 14,000 rpm to pellet insoluble
debris. All 25 III of the supernatant was loaded onto an 80S-PAGE gel.
Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (8DS-
PAGE): For the 10% running gell, 4 ml of lower buffer (1.5 M Tris-HCI at a pH 8.8)
was added to 4 ml 40% acrylamide:bis (Bio-Rad at a ratio of 39:1 and 37.5:1),
7.67 mil nanopure water, 1160 III 10%3D3, 160 III 10% APS (ammonium
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persullfate) and 16 III TEMEO (Bio-Rad). For the 5 % stacking, gel, 750 III upper
buffer (0.5 M Tris-HGI at a pH 6.8) was added to 750 J.tI 40% acryl:amide, 4.38 ml
nanopure water, '60 III 10% SOS, ,60 III 10% APS, and 6 j.L1 N,N,N,N'-Tetra-
methyl-ethylenediamine (TEMED). The separating gel was first poured and
overl!aid with a 50% water-saturated butanol. After the gel polymerized, the
butanol was rinsed off with distilled water and the stacking gel poured on top. A
running bufter was made at a concentratilon of 5X (60 g Tris base, 288 g glycine
and 20 g SDS in 4 L water) and diluted to a 1X working solution. The
electrophoresis was carried out for approximately 45 minutes at 80 volts. After
electrophoresis, the ,gel was stained with ooomassie stain (40 ml methanol, 10 ml
acetic acid, 0.1 9 coomassie blue R-250 and 50 ml distilled water) for at least two
hours and destained (50% methanol and 50% distilled water) until the






Species Name ATCC# Location* positive! Media
negative used
Bacteroides fraqilis 25285 Colon - TYG
Bacteroides stercoris 43183 Colon - TYG
, Bifidobacterium adolescentis 15703 Colon + TYG
Bifidobacterium bifidum 15696 i Colon + TYG
Bifidobacterium breve 15700 Colon + TYG
Bifidobacterium infantis 15697 Colon + TYG
Bifidobacterium !ongum 115707 Colon + TYG
Clostridium perfringens 119574 Colon + TYG
Enterococcus faecalis 27274 Colon + TYG
Enterococcus faecium 6569 Colon + TYG ,
Escherichia coli 11698 Colon - TYG
Eubacterium eligans 27750 Colon + BHI
Eubacterium rectale 33656 Colon + BHI
I Lactobacillus acidophilus 4356 Stomach + TYG
, Ruminococcus productus 27340 Colon + BHI
Staphylococcus aureus 13150 Stomach + TYG
Streptococcus intestinalis 43492 Colon + BHI
Table 4. Bacterial strain grown and tested for the presence of cytochrome P450
induced with phenobarbital. All strains with the exception of S. intestinafis were
isolated from the human intestine. S. intestinaJis was isolated from swine. The












Each strain was grown anaerobically to saturation (stationary phase) in
the presence and absence of 5mM phenobarbital. The average time of growth
was 24 hours. Based on vislJal turbidity analysis of the plus and minus
phenobarbital samples, phenobarbital did not appear to inhibit the growth of the
bacterial cultures exposed to phenobarbital. Two bacterial fractions, fraction 1
from the cytopl,asm and fraction 2 from a membrane-bound soluble preparation
were collected under anaerobic conditions. The protein fractions were isolated
under anaerobic conditions in order to reduce the level of free oxygen molecules
interaction with the anaerobic proteins. Many anaerobic bacteria lose their
reductive activity after oxygen exposure. Since activity of the P450 enzyme and
the 450 nm peak are coupled, the Ilevel of oxygen exposure to the samples was
limited. The reduoed carbon monoxide (CO) difference spectrum was performed
on all fractions. Table 5 summarizes the CO difference data for all strains tested.
The data for the induced fraction 1 samples were the following.
Bifidobacferium infantis produced a peak at 584 nm, Clostridium perfringens
produced two peaks at 424 and 581 nm, Ruminococcus productus produced a
peak at 575 nm, and Streptococcus intestinalis produced two peaks at 416 and
572 nm. The data for the non-induced fraction 1 samples were the following.
Bacteroides stercoris produced two peaks at 415 and 575 nm and







The data for the induced fraction 2 sample were the following. Clostridium
perfringens produced a peak at 420 nm, but not a peak at 581 nm as seen with
the induced fraction 1. S. intestinalis produced two peaks at 416 and 575 nm,
which was similar to the induced fraction 1 sample. R. productus did not produce
a peak in induced fraction 2, compared to a 575 peak in the induced fraction 1
sample. There were no peaks observed in fraction 2 non-induced samples.
Species Name Protein Fraction 1 Protein Fraction 2
Non-l nduced Induced Non-I nduced Induced
(nm) (nm) (nm) (nm)
Bacteroides fraqilis None None None None
Bacteroides stercoris 415,575 None None None
Bifidobacterium None None None None
adolescentis
Bifidobacferium None None None None
bifidum
Bifidobacferium breve None None None None
Bifidobacferium infanUs None 584 None None
Bifidobacterium 480,5,73 573 None None
fonqum
. Clostridium perfringens None 424,581 None 420
Enterococcus faecalis None None None None
Enterococcus faecium None None None None
Escherichia coli None None None None
Eubacterium eligans None None None None
Eubacterium rectale None None None None
Lactobacillus None None None None
acidophi1us
Ruminococcus None 575 None None
productus
Staphylococcus aureus None None None None
Streptococcus None 416,572 None 416,575
intestinaJis
Table 5. Protein fractions. The numbers represent wavelengths (nm) for non-
induced and induced proteins based on the reduced CO difference spectrum
assay. Fraction 1 represents proteins from the cytoplasm and fraction 2





Species Name Repression molecular Induction
weight (kDa) molecular weight (kDa)
Bacteroides fragilis None None
Bacteroides stercoris 47 None
Bifidobacterium adolescentis None 38 and 42
Bifidobacterium bifidum 66 None
Bifidobacterium breve None 28
Bifidobactefium infantis 25 20
Bifidobacterium longum 28 35
Clostridium perfringens None None
Enterococcus faecalis None None
Enterococcus faecium None None
Escherichia coli None None
Eubacterium eligans 30 66
Eubacterium rectale None None
Lactobacillus acidophilus None None
Ruminococcus productus None None
Staphylococcus aUfieus None None
Streptococcus intestinalis None 68
Table 6. The SOS-PAGE results of the protein profile. Bacterial strains that had
an induction or a repression of proteins with 5mM phenobarbital.
Both non-induced and induced samples from both the cytoplasm and
membrane-bound preparations were analyzed by one-dimensional SDS-PAGE.
Table 6 summarizes the results for all bacterial strains tested. The induced
proteins produced the following; results. B. longum produced a protein band at a
molecular weight of 35 kDa for fraction 1 (Table 6 and Fig. 6A lane 2), B. in fantis
produced a protein band at 20 kDa for fraction 1 (Table 6 and Fig. 6B lane 3), B.
breve produced a protein band at 28 kDa for fraction 2 (Table 6 and Fig. 6B lane
9), B. adolescentis produced two protein bands at 38- and 42 kDa for fraction 2
(Table 6 and Fig. 7A lane 4), E. efigans produced a protein band at 66 kDa for
fraction 2 (Table 6 and Fig.7B lane 4), and S. intestinalis produced a protein
band at 68 kDa for fraction 2 (Table 6 and Fig.7e lane 4). The arrows for each















Fig 6. The One-Dimensional SOS-PAGE. A) Lane 1, B. Jongum fraction 1 non-
induced; and lane .2, induced fraction 1. Lane 2 g:enerated an induced protein
near 35 IkDa. B) Lane 1 molecullar weight marker. Lane 2, B. infantis fraction 1
non-induced; lane 3, fraction 1 .ilnduced; lane 4, fraction 2 non-induced; and lane
5 fraction 2 induced.. Lane 3 generated an induoed protein near 20 kDa. Lane 6,
B. breve fraction 1 non-induced; lane 7 fraction 1 induced; lane 8 fracbon 2 non-
induced; and lane 9 fractilon 2 induoed. Lane 9 generated an induced protein
near 28 kDa. The repressed proteins are not shown.
A B
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Fig 7. The One-dimensional SDS-PAGE. A) Lane 1, B. adolescentis fraction 1
non-induced; lane 2 fraction 1 induced; lane 3 fraction 2 non-induced; and 4
fraction 2 induced. Lane 4 generated two induced protein bands near 42- and 38
kDa. B) Lane 1, E. eHgans fraction 1 non-induced; lane 2 fraction 1 induced; lane
3 fraction 2 non-induced; and 4 fraction 2 ilnduced. Lane 4 generated an 'inducible
band near 66 kDa. C) Lane 1, S. intestinalis fraction 1 non-induced; lane 2
fraction 1 induced; lane 3 fraction 2 non-induced; and 4 fraction 2 induced. Lane
4 generated an induced protein near 68 kDa. The molecular weight marlker is not
shown. The repressed proteins are not shown.
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Discussion
The objective of the study was to look for evidence of P450 in major
bacterial strains of lintestinal bacteria. Thiis was accomplished by inducing the
bacterial cultures with phenobarbital, which is a common inducer for many
mammalian and bacteri,al P45,Qs. The two tests used to detect the P450 protein
"
in different protein preparations were the CO difference spectra and the one-
dimensional 80S-PAGE. The CO difference absorbance spectra test was used
to determine the absorbance peak at or near the predicted 450 nm region or near
the 420 nm region. The one-dimensionall SOS-PAGE was used to analyze the
protein profile of induced and non-induced samples from the different fraction
preparations. The SOS-PAGE was aliso Llsed to determine the presence of an
induced protein near the 45-55kOa or 119kOa range, which is indicative of
cytochrome P450.
The CO difference spectrum data for some of the bacterial stains tested
resulted in a number of different absorbance peaks ranging from 415 nm to 584
nm. Most of the spectrum occurred with the induced samples, suggesting that
phenobarbital affected the production of proteins. These proteins were then able
to react with the reducing and oxidation agents, thereby, producing a spectrum
profile. The spectrums from non-induced samples were probably caused by
constitutive proteins, as phenobarbital was not present.
The presence of phenobarbital in the cultures affected the expression of
some of the bacterial stains tested, as the proteins expressed ranged in size from
20kDa to 68 kOa.lnterestingly, phenobarbital caused the repression of some
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proteins in some of the bacterial strains tested. The molecular mechanism
associated with the observed responses is complex, as it is not known if
phenobarbital acted as a positive regulator or as a negative regulator. What is
known is that phenobarbi,tal influenced the expression of a number of proteins in
different bacterial cultures. Future studies to i:dentify these induced proteins
would shed some light as what proteins are affected by phenobarbital.
C. perfringens and S. intestinalis produced a CO d.ifference spectrum
near 420 nm, which is similar to denatured cytochrome P450. However, only S.
intestinalis produced an induced protein near 55 kDa. Therefore S. intestinalis
was selected for further characterization.
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Chapter IV
The Identification of Two Proteins From Streptococcus intestinaHs
Int!roduction
Streptococcus intestinalis is a gram-positive anaerobe. It is a naturally-
occurring ureolytic streptococcus isolated from swine feces. It was first isolated
in 1988 by Robinson et. al. ([31]) whil.e studying ammonia production by bacteria
in urea. In 1999, however, Vandamme et. al.( [32]) determined that
Streptococcus intestinalis and Streptococcus alactolyticus were phenotypically
indistinguishable, based on the whole-cell protein electrophoresis and
biochemical tests.
S. intestina/is is an intestinal microflora. As with other intestinal strains, its
metabolic capacity, is not fully understood. This study determined the ability of
S. intestina/is to grow in the presence of 5mM phenobarbital, a compound used
to induce cytochrome P450. The hypothesis is that intestinal bacteria, like S.
intestinalis , possess a cytochrome P450 system that is involved in metabolizing
different xenobiotics thereby influencing the expression of hepatic cytochrome
P450. It has been shown in animal studies that intestinal flora can influence the
expression of hepatic cytochrome ([33]). But the presence of cytochrome P450
or cytochrome P450-like proteins in intestinal bacteria has not been extensively
studied.
In the presence of phenobarbital, the growth rate of S. intestina/is was
analyzed. In addition, the presence of induced proteins was determined based
on 80S-PAGE analysis. Induced proteins from S. intestinalis were purified by 2-
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D SDS-PAGE anoN-terminally seqlJenced. The induced proteins resembled
OprF. a pOdnprotein, and GroEL. a heat shockproteinJ from Pseudomonas spp~
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Methods and Materials
Bacterial strain: Streptococcus intestinaHs (ATeC # 43492) was
purchased from The American Type Culture Collection.
Culture media: BHI: For 500 ml of medi:um, 18 9 of Braiin Heart Infusion,
2.5 9 yeast extract, 425 ml dH20, 12.5 ml salt solution 1 (3 9 K2HP04 in 1 liter
water), 12.5 ml salt solution 2 (3.54 9 KH2P04 , 9 9 (NH4)2S04, 0.9 9 NaCI, 1.9 9
MgS04 in SOD ml water), 12.5 ml CaCh solution (0.6 9 CaCh in 1 liter water), 2.0
ml hemin (50 mg hemin, 1 ml 1N NaOH in 100 ml water), 1 ml Wolfe's mineral.
solution(2X) (1.5 9 nitrilotriacetic acid, 3g MgS04-7H20, 0.5 9 MnS04-H20, 1 9
500 ml water) and 5.0 ml resazurin (0.25 9 resazurin in 500 ml water) were
added. The medium was then boiled using a microwave for 5 minutes and
degassed (bubbled) with N2 for .30 minutes. When the BHI was approximately
40°C, 5 ml vitamin K solution (50 mg menadione in 100 ml 95% EtOH) and 0.3 9
cysteine-Hel were added. The pH was adjusted to 7.0. The solution was then
bubbled for another 10 minutes. A total of 10 ml H20 with 10 ml volatile fatty
acids (42.5 ml acetic acid, 15.0 ml propionic acid, 10.0 ml butyric acid, 2.5 ml
isobutyric acid, 2.5 ml valerie acid, 2.5 ml isovaleric acid and 2.5 ml methylbutryic
acid with the pH adjusted to 9.5 and the volume made up to 500 ml with ddHzO)
and 0.2 9 sodium carbonate were added into a 100 ml bottle. The bottle was
sealed and autoclaved with the BHI solution.
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After autoclaving, the N2 was bubbled into the BHI solution until ,the solution was
less than 50°C. Aseptically, 20 ml 20% anaerobic glucose, 20 ml volatile fatty
acid, 10 ml reducing agent (110 ml distiHed water microwaved for two minutes,
gassed with N2 until room temperature, then 2.5 9 cysteine-HCI added, the pH
adjusted to 9.0 using 5 N NaOH, and 25 9 Na2S.9H20 were added and placed
in N2 equilibrated bottles, and autoclaved) and 1 ml 10X vitamins (5 mg
riboflavin, 100 1-19 Vitamin B12, 5 mg pyridoxine(B6), 5 mg pyridoxal, 5 mg
pyridoxamine, 5 mg pantothenate-Ca, 3 mg nicotinic acid, 3 mg nicotinamide, 2
mQi biotin, 2 mg folic acid, 5 mg thiamine(B1), 5 mg thioctic acid and 5 mg p-
amino benzoic acid were added to 50 ml distilled water and filter sterilized
(0.211m) and placed jnto N2 equilibrated bottles and sealed) were added to the
solution, competing, the BHI medium. The medium was placed in an anaerobic
chamber and incubated at 37°C overnight to test for contamination.
Growth curve: Two 5 ml tubes of BHI were inoculated with 100111 of an
overnight culture of S. intestinalis. Phenobarbital was added (final concentration
5 mM) to one tube. A spectronic 200 (Milton Roy, Rochester, NY)
spectrophotometer was used to measure the optical density at 590 nm. A
separate tube containing only media served as a blank control. Measurements
were recorded for both actively-growing cultures every 30 minutes for up to six
hours.
Protein Extraction: The 500 ml: culture, induced or non-induced, of bacteria
was separated linto two equal parts in N2 equilibrated 250 ml Nalgene anaerobic
bottles. Using a Sorvall centrifuge (GSA-13 rotor, Newtown, CT), the samples
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were centrifuged at 1,0,000 rpm for 15 minutes :at 4°C. After centrifugation, the
bottles were placed back into the anaerobic chamber and the supernatant was
removed. Each pellet was washed with 10 ml of the anaerobic Mops buffer (1,00
mM Mops (pH 7.3), 10% ,glycerol, 0.2 mM dithiothreitol, and 1mM EDTA) and
combined fora total of 20 ml Mops buffer. The suspension was then transferred
to a Nz-equiHbrated 50 ml centrifuge tube and sealed with an anaerobic cap. The
suspension was again centrifuged at 10,000 rpm for 15 minutes at 4°C. In the
anaerobic chamber the supernatant was removed and 10 mi· of fresh Mops buffer
was added and the pellet was re-suspended and incubated for two hours at 37°C
with 1Dill mutanolysin. The suspension was placed on ice for 2 minutes. Once
cooled, the sample was sonicated under Nz gas. Using a flat tip sonicator probe,
the pulse was set for 2 seconds for a total of 25 times. The sample was placed
on ioe for 2 minutes and the above step was repeated twice more. In the
anaerobic chamber, the sample was transferred to an ultra-centrifuge tube that
was equilibrated with Nz. The sample was centrifuged in the ultra-centrifuge, at
31,000 rpm for 35 minutes at 4°C in a Ti-70 rotor. In the anaerobic chamber the
supernatant was fractionated into 1.5 ml anaerobic tubes that were equilibrated
with Nz. The supernatants were labeled fraction 1 and stored at -BO°C. CHAPS
(0.05 g) and 10 mil MOPS buffer were added to the pellet The sample was
stirred overnight at 4°C with a metal stir bar and magnetic stirrer. The ultra-
centrifugation and fractionation was repeated.
Protein determination: To determine the protein concentration, the 8io-
Rad DC (Detergent Compatible) protein assay from Bio-Rad was used. The
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absorbance was analyzed at 750 nm using a Shimadzu spectrophotometer
(Columbia, MD).
Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (80S-
PAGE): For the 10% running gel, 4 ml of lower buffer (1.5 M Tris-Hel at a pH
8.8) was added to 4 ml 40% acrylamide (Bio-Rad at a ratio of 39:1 and 37.5:1),
7.67 ml nanopure water, 160 ~I 10%SOS, 160 ,.11 10% APS (ammonium
persulfate) and 16 ~I TEMEO (Bio-Rad). For the 5 % stacking giel, 750 J.d upper
buffer (0.5 MTris-HCI at a pH 6.8) was added to 750 ~I 40% acrylamide, 4.38 ml
nanopure water, 60 JlI 10% 80S, 60 ~J 10% APS, and 6 ~I TEMED. The
separating gel was first poured and overlaid with 50% water-saturated butanol.
After the gel polymerized, the butanol was rinsed off with distilled water and the
stacking gel poured on top', A running buffer was made at a concentration of 5X
(60 g tris base, 288 g glycine and 20 g SOS in 4 L water)' and diluted to 1X as a
workIng solution. The electrophoresis was carried out for approximately 45
minutes at 80 volts. After electrophoresis, the gel was stained with a coomassie
stain (40 ml methanol, 10 ml acetic acid, 0.1 g coomassie blue R-250 and 50 ml
distilled water). The gel was stained' for at least two hours and destained (50%
methanol and 50% distilled water) until the background was removed. The 96'1
was then dried on an air dryer (Bio-Rad).
2-D gel electrophoresis: For the first dimension gel, 5.5 9 of urea was
added to 1.33 ml 40% acrylamide (Bio-Rad at a ratio of 37.5:1) along with 2.0 ml
10% Triton X-100 and 0.400 ml Bio-Lyte 3/10 ampholyte and 0.100 ml Bio-Lyle
5/7 ampholyte and 1.97 ml distilled water. The s01ution was warmed, vortexed
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and degassed for 15 minutes. For polymerization, 10 111 of 10% ammonium
persulfate and 10 ~I TEMED were added and poured in the casting tube until it
was three-fourths of the length of the capiUary tubes. (Note: one end of the
casting tube was sealed with several layers of parafilm and the capiHary gel
tubes were then placed, with the blue end up, in the casting tube). After
polymerization, the parafilm was slowly removed from the bottom of the casting
tube and the capillary tubes removed. The tubes were connected to the
apparatus and the bottoms of the tubes were rinsed with lower buffer (0.068 %
(v/v) H3P04). Each sample reservoir was filled with degassed upper buffer (2 M
NaOH). A stir bar was placed in the lower chamber along with the tube ge:1
adapter. The lower buffer was added to the lower chamber, up to the blue line
on the glass gel tubes. The upper chamber was filled with upper buffer, just
above the sample reservoirs. The gel tubes were then electrophoresed at 200 V
for 10 minutes, 300 V for 15 minutes and 400 V for 15 minutes as a pre-
electrophoresis step. After the pre-electrophoresis was completed, the upper
and lower buffers were discarded and replaced with fresh upper and lower buffer.
A 10 ~'I amount of the sample was added to an equal volume of the first
dimension sample buffer (8M urea, 2.0% Triton X-100, 5% p-mercaptoethanol,
1.6% Bio-Lyte 5/7 ampholyte and 0.4% Bio-Lyte 3/10 ampholyte) and incubated
at room temperature for 15 minutes and then loaded into the tube gel. The
sample was then overlaid with a 40 ~I overlay buffer (8.5 M urea, 0.8% Bio-Lyte
5/7 ampholyte, 0.2%, Bio-Lyte 3/10 ampholyte and bromophenol blue). The
sample was then electrophoresed for 10 minutes at 500 V and 750 V for 3.5
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hours. The gel was removed from the tube with a 1.0 ml syringe attached to the
white end of a tube gel ejector. The capillary tube was inserted into the colored
end of the unit. The tube gel was extruded onto a piece of parafilm and
equilibrated with SOS sample buffer (0.0625 M Tris Hel, pH 6.8, 2.3% (w/v) SOS,
5.0% (v/v) p-mercaptoethanol, 10% glycerol (w/v), bromophenol blue and dHzO)
for 10 minutes. The same conditions for 1-0 SDS-PAGE were also used for the
second dimension gel.
Protein transfer: The 2-0 SOS-PAGE was soaked in a transfer buffer
(48mM Tri,s base, 39 mM glycine, 20% methanol (MeOH), 1.3 mM SOS) for 15
minutes and placed in a Bj,o-Rad mini-western Blot apparatus. A PVDF
membrane, pre-soaked for 5 seconds in MeOH and rinsed with transfer buffer,
was placed in the transfer buffer. The cassette apparatus was set up in the
following order, starting from the negative side: sponge, filter, g,el, membrane,
filter and sponge (making sure no bubbles were present on the membrane). The
cassette was placed in the modul,e and a frozen Bio-tee cooling unit was added.
The tank was completely filled with pre-cooled transfer buffer. A stir bar was
added to the tank and the entire apparatus was placed in a refrigerator to
minimize heating. The power supply was set at 100V for one hour. After
transfer, the membrane was rinsed with 100% MeOH and then stained (0.1 g
coomassie G-250, 40 ml MeOH, 1.0 ml acetic acid and 59 ml ddHzO stirred for
30 minutes and filtered through a 0.451-l filter) for 60 seconds. The membrane
was then de-stained for 2 hours with 50% MeOH and 50% dHzO.
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Protein Sequence: The nitrocellulose membrane, containing the
transferred protein, was sequenced by Ken Jackson, Ph.D. at the Molecular
Biology Resource Facility, University of Oklahoma Health Science Center
(OUHSC).
Basic Local Alignment Search Tool (BLAST) ([23]t A BLASTP was used
for protein matching. A BlASTP compares an amino acid query sequence
against a protein sequence database. The output from the BLAST search had
two critical sets of data: an expected value (e-value) and a score number. An e-
value number is equivalent to the number of random hits that occur by chance
when searching a database of a given size. The e-value increases exponentially
with the score number that is assigned to a match between two sequences.
Essentially the e-value described the random background noise that exists for
matches between sequences.
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The growth curves for a non-induced and an induced (5 mM
phenobarbital) culture of S. intestinalis were determined (Fig. 8). Duplicate
sampl·es were recorded every 30 minutes for approximately 6 hours.



















I-+-Induced avg. ---Non-induced avg.1
Fig. 8. The growtih curve of S. intestinalis grown anaerobicaHy at 3rC in
BHlI media for over 6 hours. The points represent the average of duplicates. The
non-induced sample had a doubling time of 0.153 cells/hr and the induced
sample had a doubling time of 0.128 cells/hr.
48
The presence of phenobarbital resulted in no significant difference In the I'ag, log,
or stationary phase for both the non-induced and induced samples {Fig. 8)
The protein profiles tor the non-induced and induced cul,tures were first
analyzed by 1-0 SDS-PAGE. A 50 kDa and -68 kDa protein were produced in the
induced sample (Fig. 9). The expression level for the 50 kDa protein was much
higher in both cytoplasmic (fraction 1) and membrane-bound protein (fraction 2)
fractions (molecular weight marker not shown), when compared to the 68 kDa
protein (Fig.9).
1 2 3 4
Fig. 9. 1-D SDS-PAGE S. intestinalis. (Fraction 1 is cytoplasmic and fraction 2 is
membrane-bound proteins) Lane 1, non-induced fraction 1; lane 2, induced
fraction 1; lane 3, non-induced fraction 2; and lane 4, induced fraction 2. Arrow A
indicates an induced protein near 50 kDa in both fraction 1 and fraction 2 and
arrow B an induced protein at 68 kDa in lane 4.
Fraction 2, which contained the induced proteins (50 kDa and 68 kDa)
was further purified using the 2-D SDS-PAGE method. The fraction generated
proteins at 60 kDa, 50 kOa and 40 kDa, when compared to the non-induced 2-D
50S-PAGE gel. The 68 kDa-induced protein was very close to other proteins on
the gel and it was not purified and sequenced. Figure 10 compared the 2-D
SDS-PAGE non-induced and induced fraction 2 samples.
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The 40 kDa protein (pI 5.0) was purified and sequenced by N-terminal
amino acid sequencing. The sequenced results were Gln-Gly-Gln-Gly-Ala-Val-
Glu-Gly-Glu-lIe-Asn-Tyr. A BLASTP search with the amino acid sequence
revea:led a score of 53 and 25.1 bits with an e-value of 111 to protein OprF, a
porin protein from Pseudomonas fuscovaginae. The 60 kDa protein (pi 6.0) was
purified and also sequenced by N-terminal amino acid sequencing.. The
sequence results were Ala-Ala-Lys-Glu-Val-Lys-Phe-Gly-Asp-Ala-Ala-Arg. A
BLASTP search revealed a score of 55 and 25.8 bits with an e-value of 65 to the
GroEL, a heat shock protein of Pseudomonas aeruginosa. The 50 kDa (pi 7.0)
was not sequenced due to a possible N-terminal blockage. Trypsinization and
HPLC purification were attempted to prevent N-terminal blockage, but the
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Fi,g. 10. 2-D gel electrophoresis of S. intestinalis fraction 2. (A) Non-induced and
(8) induced. The samples were run 011 a 5% stacking gel and a 12% separating
gel. In gel A, arrows show repressed proteins near 42 kDa, 48 kDa, and 97 kDa.




. The metabolic capacity of intestinali bacteria is very diverse, as they are
capable of metabolizing. various xenobiotics. Unfortunately, their full metabolic
capacity is not completely understood. To better understand their metabolic
capacity, S. intestinaHs, a microorganism found in the intestine of swine, was
selected for further characterization. The growth characteristics and protein
expression of S. intesUnalis in the presence of phenobarbital was investigated.
S. intestinalis was able to grow in the presence of 5 mM phenobarbital
without significant.ly affecting the growth rate. However, S. intestinafis did
produce a number of phenobarbital inducible proteins in the membrane-bound
fraction (fraction 2). The 40 kDa protein was more than 90% similar to OprF, a
majlOr outer membrane porin protein in P. fuscovaginae, a psychrotrophic
bacterium. The OprF porin forms cross-membrane channels through whi:ch
small molecules can diffuse. The porin protein also is considered an attachment
protein. The OprF porin protein is present in a number of Pseudomonas species
([34], [35]). Interestingly, P. fuscovaginae is a pathogenic, Gram-negative
bacterium ([36], [37]) while S. intestinalis is a Gram-positive bacterium. Since
some Streptococci spp. are pathogenic, a protein with conserved regions may
exist between P. fuscovaginae and S. intestinalis.
The 60 kDa protein was sequenced and identified as the GroEL (HSP60)
protein, which more than 99% similarity to P. aeruginosa, a Gram-negative
bacterium. GroEL is a stress protein or a heat shock protein. Since heat shock
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proteins are conserved proteins ([38]), it is possible that S. intestinalis and P.
fuscovaginae possess similar proteins.
The results from thi,s study demonstrated that S. intestinalis has similar
proteIns to P. fuscovaginae and P. aeruginosa. It is unlikely that an
outermembrane porin protein is present in S. intestinalis , as Gram positive
bacteria do not have outer membrane proteins. However, it is possible that a
cytoplasmic protein in S. intestinalis may resemble the OprF protein. Heat shock
protein were originally discovered as oells responded to elevated temperatures.
Heat shock proteins are also related to survival of cells under stressful,
conditions. As a result, heat shock proteins are evolutionari\y conserved among
bacterial, archaeal, and eukaryoticcells. Therefore, it very possible that S.
intestinalis may have a similar heat shock protein 'that' resembles the GroEL
protein from P. aeruginosa. Heat shock proteins are also said to help enhance






The overall goal of this project was to screen intestinal micro-fllora for the
presence of cytochrome P450. Intestinal bacterila were chosen for the following
reasons: 1) they share reductive reactions with cytochrome P450, 2) there is
Ilimited data published on the presence of cytochrome P450 in intestinal
microflora, and 3) intestinal microflora playa major metabolic role in human
physiiologlY·
The methods associated with the project were first developed as they
included bacterial DNA preparation, peR amplification, and sequencing. Based
on these developed methods, studies involving the screening of selected
intestinal strains for cytochrome P450 were performed.
The following summarizes the overall study: First, five out of eighteen
bacterial strains tested, produced an absorbance spectrum when exposed to
phenobarbital. No peaks were produced at 450 nm, although two strains
produced a peak near the 420 nm mark, suggesting a denatured cytochrome
P450. Second, six out of the eighteen strains were positive for an induction of a
protein based on the 1-D SOS-PAGE gel. No induced proteins were produced at
the predicted size for cytochrome P450 (45-55 kOa and 119 kDa). Of these six
strains, B. infantis and S. intestinaJis produced a spectrum based on exposure to
phenobarbital. Third, S. intestinalis was further studied as it was selected based
on the fact that the induced protein bands from the 10 SOS-PAGE gel were
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clearly separate from other non-induced proteins. The induced proteins from S.
intestinalis were subsequently sequenced. The sequenced information
determined that the proteins were a porin protein and a heat shock protein.
Based on the lack of a specific peak at 450 nm or 420 nm and no
phenobarbital induction at the predicted size range (45 kDa and 116 kDa), it
appears that the selected strains of intestinal bacteria from the human and the
single swine isolates do not contain cytochrome P450. In addition. sequence
information did not match with existing cytochrome P450 families. It should be
noted that other minor induced proteins from the other bacterial species were
characterized. The characterization of those proteins may provide some
interesting data regarding the response these bacterial species had against
phenobarbital.
The hunt for P450s in intestinal bacteria may involve using a different
inducer. Finally, the complete genome sequencing of major intestinal flora will
provide information regarding the presence of a cytochrome P450 or a P450-like
protein. Therefore, the work associated with finding the a cytochrome P450 in
intestinal bacteria is far from over.
Recently, the bacterium Eubacterium aerofacians was shown to possess a
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